✦ LIBER ✦

Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells

✍ Scribed by Waller, Edmund K.; Johnson, Heather Renfroe; Jagirdar, Neera; Gaylor, Cynthia; Lipscomb, Carol; Flowers, Christopher; Kaufman, Jonathan; Khoury, H. Jean; Langston, Amelia; Lechowicz, MaryJo; Lonial, Sagar; Nooka, Ajay; Sinha, Rajni; Harvey, R. Donald

Book ID: 122091885
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 62 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.11.195

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mobilization of peripheral blood progeni

Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy

✍ Waller, C F; von Lintig, F; Daskalakis, A; Musahl, V; Lange, W 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 60 KB

Mobilization of Hematopoietic Progenitor

Mobilization of Hematopoietic Progenitors from Normal Donors Using the Combination of Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor Results in Fewer Plasmacytoid Dendritic Cells in the Graft and Enhanced Donor T Cell Engraftment with Th1 Polarization: Results from a Randomized Clinical Trial

✍ Lonial, Sagar; Akhtari, Mojtaba; Kaufman, Jonathan; Torre, Claire; Lechowicz, Ma 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 686 KB

The feasibility of neoadjuvant high-dose

The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma : Results of a phase II study

✍ Fikret Arpaci; Selmin Ataergin; Ahmet Ozet; Kaan Erler; Mustafa Basbozkurt; Ayha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract ## BACKGROUND The primary and secondary objectives of the current study were to improve the ≥ 90% tumor necrosis rate and assess the toxicity profile of the neoadjuvant high‐dose chemotherapy (HDC) regimen, respectively. ## METHODS Twenty‐two patients with AJCC Stage IIB high‐grade o

Safety and efficacy of the combination o

Safety and efficacy of the combination of trastuzumab with docetaxel for HER2-positive women with advanced breast cancer. A review of the existing clinical trials and results of the expanded access programme in the UK

✍ K.T. Papazisis; T. Habeshaw; D.W. Miles 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Efficacy and safety of ustekinumab in Ja

Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: Long-term results from a phase 2/3 clinical trial

✍ Atsuyuki IGARASHI; Takeshi KATO; Mai KATO; Michael SONG; Hidemi NAKAGAWA; THE JA 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 462 KB

53 POSTER A phase II, multicenter, rando

53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer

✍ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB